IMA Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $78.9K | Hold |
566
| – | – | 0.01% | 225 |
|
|
2025
Q4 | $69.5K | Buy |
566
+64
| +13% | +$7.78K | 0.01% | 228 |
|
|
2025
Q3 | $55.7K | Buy |
502
+144
| +40% | +$16.4K | 0.01% | 236 |
|
|
2025
Q2 | $39.7K | Buy |
358
+9
| +3% | +$958 | ﹤0.01% | 243 |
|
|
2025
Q1 | $39.1K | Buy |
+349
| New | +$36K | ﹤0.01% | 244 |
|
|
2024
Q4 | – | Sell |
-104
| Closed | -$8.72K | – | 216 |
|
|
2024
Q3 | $8.72K | Buy |
+104
| New | +$7.94K | ﹤0.01% | 242 |
|
|
2023
Q2 | – | Sell |
-36
| Closed | -$2.99K | – | 303 |
|
|
2023
Q1 | $2.99K | Hold |
36
| – | – | ﹤0.01% | 275 |
|
|
2022
Q4 | $3.09K | Hold |
36
| – | – | ﹤0.01% | 300 |
|
|
2022
Q3 | $2K | Hold |
36
| – | – | ﹤0.01% | 299 |
|
|
2022
Q2 | $2K | Hold |
36
| – | – | ﹤0.01% | 304 |
|
|
2022
Q1 | $2K | Hold |
36
| – | – | ﹤0.01% | 287 |
|
|
2021
Q4 | $3K | Hold |
36
| – | – | ﹤0.01% | 291 |
|
|
2021
Q3 | $3K | Hold |
36
| – | – | ﹤0.01% | 271 |
|
|
2021
Q2 | $2K | Hold |
36
| – | – | ﹤0.01% | 273 |
|
|
2021
Q1 | $2K | Sell |
36
-163
| -82% | -$10.5K | ﹤0.01% | 280 |
|
|
2020
Q4 | $12K | Sell |
199
-40,341
| -100% | -$2.43M | ﹤0.01% | 214 |
|
|
2020
Q3 | $2.56M | Sell |
40,540
-1,636
| -4% | -$113K | 0.86% | 37 |
|
|
2020
Q2 | $3.25M | Sell |
42,176
-13,100
| -24% | -$1M | 1.17% | 23 |
|
|
2020
Q1 | $4.13M | Buy |
55,276
+11,560
| +26% | +$799K | 1.82% | 11 |
|
|
2019
Q4 | $2.84M | Buy |
43,716
+13,456
| +44% | +$876K | 1.05% | 37 |
|
|
2019
Q3 | $1.92M | Buy |
30,260
+578
| +2% | +$37.8K | 0.72% | 57 |
|
|
2019
Q2 | $2M | Buy |
29,682
+984
| +3% | +$64.7K | 0.75% | 59 |
|
|
2019
Q1 | $1.87M | Buy |
28,698
+21,577
| +303% | +$1.43M | 0.72% | 60 |
|
|
2018
Q4 | $445K | Buy |
7,121
+1,710
| +32% | +$120K | 0.21% | 83 |
|
|
2018
Q3 | $418K | Buy |
5,411
+314
| +6% | +$23.7K | 0.16% | 90 |
|
|
2018
Q2 | $361K | Sell |
5,097
-206
| -4% | -$14.5K | 0.15% | 97 |
|
|
2018
Q1 | $400K | Hold |
5,303
| – | – | 0.18% | 101 |
|
|
2017
Q4 | $380K | Sell |
5,303
-3,667
| -41% | -$278K | 0.17% | 110 |
|
|
2017
Q3 | $727K | Sell |
8,970
-295
| -3% | -$22.6K | 0.34% | 89 |
|
|
2017
Q2 | $656K | Sell |
9,265
-260
| -3% | -$17.3K | 0.32% | 94 |
|
|
2017
Q1 | $647K | Buy |
9,525
+338
| +4% | +$23.8K | 0.33% | 95 |
|
|
2016
Q4 | $658K | Buy |
9,187
+3,571
| +64% | +$265K | 0.41% | 81 |
|
|
2016
Q3 | $444K | Buy |
+5,616
| New | +$456K | 0.25% | 86 |
|
|
2015
Q3 | – | Sell |
-3,040
| Closed | -$356K | – | 140 |
|
|
2015
Q2 | $356K | Buy |
3,040
+970
| +47% | +$106K | 0.17% | 105 |
|
|
2015
Q1 | $203K | Buy |
+2,070
| New | +$210K | 0.1% | 146 |
|
Other funds holding GILD
VCM
VPM
IMA Advisory Services's GILD Position: Q1 2026 in Review
IMA Advisory Services held its Gilead Sciences (GILD) position steady in Q1 2026 at 566 shares worth $78.9K. The position accounts for 0.01% of the portfolio, ranked #225.
IMA Advisory Services first reported a position in GILD in Q1 2015 and has held it in 35 quarters since. The position peaked at $4.13M in Q1 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- IMA Advisory Services held 566 shares of Gilead Sciences worth $78.9K as of Q1 2026.
- IMA Advisory Services left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.01% of IMA Advisory Services's portfolio in Q1 2026, its #225 holding.
- IMA Advisory Services first reported a position in Gilead Sciences in Q1 2015 and has held it in 35 quarters since.
- IMA Advisory Services's Gilead Sciences position peaked at $4.13M in Q1 2020.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.